Page last updated: 2024-08-23

bezafibrate and Neoplasms

bezafibrate has been researched along with Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM1
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L1
Brenner, R; Gerber, Y; Goldenberg, I; Hasin, T; Iakobishvili, Z; Klempfner, R; Kornowski, R; Shlomo, N1

Reviews

2 review(s) available for bezafibrate and Neoplasms

ArticleYear
The PPARs: from orphan receptors to drug discovery.
    Journal of medicinal chemistry, 2000, Feb-24, Volume: 43, Issue:4

    Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2000
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
    Nature cell biology, 2015, Volume: 17, Issue:11

    Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction

2015

Other Studies

2 other study(ies) available for bezafibrate and Neoplasms

ArticleYear
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2017, Volume: 40, Issue:4

    Topics: Animals; Bezafibrate; Disease Models, Animal; Energy Metabolism; Humans; Immunotherapy; Lymph Nodes; Mice; Mitochondria; Neoplasms; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Programmed Cell Death 1 Receptor; Reactive Oxygen Species; T-Lymphocytes; T-Lymphocytes, Cytotoxic

2017
Association of Bezafibrate Treatment With Reduced Risk of Cancer in Patients With Coronary Artery Disease.
    Mayo Clinic proceedings, 2019, Volume: 94, Issue:7

    Topics: Bezafibrate; Cholesterol, HDL; Coronary Artery Disease; Female; Fibrinogen; Humans; Hypolipidemic Agents; Israel; Lipids; Male; Middle Aged; Neoplasms; Registries; Risk Reduction Behavior; Triglycerides

2019